madiha derouazi
Speransa Therapeutics GmbH
Frankfurt, Germany
Associate Editor
Cancer Immunity and Immunotherapy
Speransa Therapeutics GmbH
Frankfurt, Germany
Associate Editor
Cancer Immunity and Immunotherapy
INSERM U938 Centre de Recherche Saint Antoine (CRSA)
Paris, France
Associate Editor
Multiple Sclerosis and Neuroimmunology
Cummings School of Veterinary Medicine, Tufts University
North Grafton, United States
Associate Editor
Microbial Immunology
Razi Vaccine and Serum Research Institute
Karaj, Iran
Associate Editor
Microbial Immunology
Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of liverpool
Liverpool, United Kingdom
Associate Editor
Cancer Immunity and Immunotherapy
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Immunity and Immunotherapy
Wenzhou Medical University
Wenzhou, China
Associate Editor
Comparative Immunology
University of Colorado Anschutz Medical Campus
Aurora, United States
Associate Editor
Antigen Presenting Cell Biology
Jilin University
Changchun, China
Associate Editor
Immunological Tolerance and Regulation
Guangdong Provincial Academy of Chinese Medical Sciences
Guangzhou, China
Associate Editor
Alloimmunity and Transplantation
Queensland University of Technology
Brisbane, Australia
Associate Editor
Immunological Tolerance and Regulation
Heidelberg University Hospital
Heidelberg, Germany
Associate Editor
Microbial Immunology
University of North Carolina at Chapel Hill
Chapel Hill, United States
Associate Editor
Viral Immunology
Department of Neuroscience, Psychology, Drugs and Child Health Area, School of Psychology, University of Florence
Florence, Italy
Associate Editor
Multiple Sclerosis and Neuroimmunology
Feinberg School of Medicine, Northwestern University
Chicago, United States
Associate Editor
Viral Immunology
Department of Nephropathology, University Hospital Erlangen
Erlangen, Germany
Associate Editor
Molecular Innate Immunity